Interestingly, SA14-14-2-vaccinated Ifnar1-/- mice were completely protected (6/6) against ZIKV infection, as compared with PBS-treated mice where 83.3% (5/6) mice succumbed to infection (Fig. 1b, c). This evidence concerns the gene IFNAR1 and Zika virus infectious disease.